Foundry Partners LLC trimmed its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 6.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,366 shares of the company’s stock after selling 533 shares during the period. Foundry Partners LLC’s holdings in DocuSign were worth $752,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. The Manufacturers Life Insurance Company raised its stake in shares of DocuSign by 2.4% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 53,508 shares of the company’s stock worth $3,322,000 after purchasing an additional 1,248 shares in the last quarter. Townsquare Capital LLC increased its holdings in DocuSign by 3.7% during the third quarter. Townsquare Capital LLC now owns 5,103 shares of the company’s stock worth $317,000 after buying an additional 183 shares during the last quarter. Captrust Financial Advisors raised its position in DocuSign by 92.3% during the third quarter. Captrust Financial Advisors now owns 38,587 shares of the company’s stock worth $2,396,000 after acquiring an additional 18,518 shares in the last quarter. Janus Henderson Group PLC lifted its stake in DocuSign by 13.1% in the third quarter. Janus Henderson Group PLC now owns 12,110 shares of the company’s stock valued at $752,000 after acquiring an additional 1,398 shares during the last quarter. Finally, Point72 Asset Management L.P. grew its position in shares of DocuSign by 8.9% in the 3rd quarter. Point72 Asset Management L.P. now owns 257,385 shares of the company’s stock valued at $15,981,000 after acquiring an additional 21,028 shares during the period. Institutional investors own 77.64% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on DOCU shares. HSBC reaffirmed a “reduce” rating on shares of DocuSign in a report on Friday, December 6th. UBS Group dropped their price objective on DocuSign from $100.00 to $90.00 and set a “neutral” rating on the stock in a research note on Friday, March 14th. Robert W. Baird set a $93.00 target price on DocuSign in a research note on Friday, March 14th. JPMorgan Chase & Co. upgraded DocuSign from an “underweight” rating to a “neutral” rating and increased their price target for the company from $70.00 to $75.00 in a research note on Monday, March 10th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $90.00 price objective on shares of DocuSign in a research report on Friday, March 14th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, DocuSign currently has an average rating of “Hold” and an average target price of $95.83.
DocuSign Trading Down 6.7 %
Shares of DOCU opened at $72.21 on Friday. The stock has a market capitalization of $14.62 billion, a PE ratio of 14.89, a P/E/G ratio of 6.94 and a beta of 1.20. The firm’s 50 day moving average is $86.02 and its 200-day moving average is $81.98. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86.
DocuSign (NASDAQ:DOCU – Get Free Report) last released its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.02. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The firm had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. During the same period in the prior year, the company posted $0.76 EPS. The company’s revenue was up 9.0% compared to the same quarter last year. Equities research analysts predict that DocuSign, Inc. will post 1.17 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, insider James P. Shaughnessy sold 7,500 shares of the firm’s stock in a transaction dated Tuesday, April 1st. The stock was sold at an average price of $81.31, for a total value of $609,825.00. Following the sale, the insider now directly owns 45,875 shares of the company’s stock, valued at $3,730,096.25. This trade represents a 14.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Teresa Briggs sold 534 shares of the business’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $87.41, for a total value of $46,676.94. Following the transaction, the director now directly owns 8,270 shares of the company’s stock, valued at approximately $722,880.70. The trade was a 6.07 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 57,851 shares of company stock worth $4,911,319 over the last ninety days. Corporate insiders own 1.66% of the company’s stock.
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
- Five stocks we like better than DocuSign
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Best Stocks Under $10.00
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.